Can immunotherapy be used to treat breast cancer? This expert Q&A explains.
In this podcast, Cancer.Net Associate Editor Dr. Lynn Henry describes a clinical trial that studied a new approach to treating HER2-positive breast cancer.
Did you know that breast cancer is the most common cancer in U.S. women, except for skin cancer? Cancer.Net Associate Editor Dr. Norah Lynn Henry shares 9 important facts about the disease.
Opioid Use in Cancer Care and the Burden of Cancer-Related Costs: Research from the 2018 Quality Care Symposium
Research highlights from the meeting include new details on the use of opioids in cancer care and the burdens of the cost of care.
"I know too much. I don't know enough." Dr. Stephanie L. Graff interviews Dr. Kelly Shanahan, an OB/GYN living with metastatic breast cancer, about what it is like being a patient who is also a doctor.
ASCO Annual Meeting 2018: Less Treatment Needed for Some Patients With Breast Cancer and Kidney Cancer, Immunotherapy for Non-Small Cell Lung Cancer, and Maintenance Chemotherapy for Rhabdomyosarcoma
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include new treatment options and improved survival for breast cancer, kidney cancer, non-small cell lung cancer, and rhabdomyosarcoma.
ASCO Annual Meeting 2018: New Insight Into Lynch Syndrome, Finding and Treating Lung Cancer, a New Targeted Therapy for Breast Cancer, and Evidence that Personalized Medicine Helps
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer.
Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma.
Mammograms are a very important part of follow-up care in women with breast cancer. But what about older women? How long should they continue to receive mammograms?